# Compassionate Use Trial for Unresectable Melanoma With Ipilimumab

> **NCT00495066** · — · NO_LONGER_AVAILABLE · sponsor: **Bristol-Myers Squibb**

## Conditions studied

- Melanoma

## Interventions

- **DRUG:** Ipilimumab

## Key facts

- **NCT ID:** NCT00495066
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2013-06-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00495066

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00495066, "Compassionate Use Trial for Unresectable Melanoma With Ipilimumab". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00495066. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*